大半球梗死再灌注治疗患者的脑水肿:HERMES荟萃分析
该研究基于7项随机对照试验的个体患者荟萃分析,纳入1764例前循环缺血性卒中患者,其中177例基线影像显示大半球梗死。结果显示,血管内取栓和再灌注与功能改善相关,但与中线移位(MLS)无关;在核心体积>130 mL或CT-ASPECTS≤3的探索性亚组中,取栓与MLS增加相关,但未带来功能改善。
要点
- 大半球梗死患者取栓和再灌注未显著增加整体MLS。
- 核心体积>130 mL或ASPECTS≤3时取栓与MLS增加相关。
- 取栓和再灌注与大半球梗死患者功能改善相关。
核心结论
- 在大半球梗死患者中,取栓和再灌注与MLS无关,但在核心体积>130 mL的亚组中取栓与MLS增加相关。
研究设计与样本
- 系统综述和个体患者水平荟萃分析,纳入7项2010年1月1日至2017年5月31日发表的比较取栓与药物治疗前循环缺血性卒中的随机对照试验(HERMES协作),共1764例患者,其中177例为大半球梗死。
主要发现
- 取栓与功能改善相关(共同比值比=2.30,95%CI 1.32–4.00),再灌注与功能改善相关(共同比值比=4.73,95%CI 1.66–13.52)。
- 取栓与MLS无关(β=−0.27,95%CI −1.52至0.98),再灌注与MLS无关(β=−0.78,95%CI −3.07至1.50),校正年龄、NIHSS评分、血糖和随访影像时间。
- 在核心体积>130 mL或CT-ASPECTS≤3的76例患者中,取栓与MLS增加相关(β=2.76,95%CI 0.33–5.20),但与功能改善无关(比值比=1.71,95%CI 0.24–12.08)。
关键数值与推荐
- 大半球梗死定义为弥散加权MRI或CT灌注缺血核心80–300 mL或非增强CT的ASPECTS≤5。
临床怎么用
- 对于大半球梗死患者,取栓和再灌注未整体增加占位性水肿风险,但核心体积>130 mL或ASPECTS≤3时需警惕MLS增加。
- 减轻脑水肿介导的继发性损伤可能进一步改善极大梗死患者再灌注治疗后的预后。
局限性
- 探索性亚组分析样本量较小(n=76),结果需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Whether reperfusion into infarcted tissue exacerbates cerebral edema has treatment implications in patients presenting with extensive irreversible injury. We investigated the effects of endovascular thrombectomy and reperfusion on cerebral edema in patients presenting with radiological evidence of large hemispheric infarction at baseline. METHODS: In a systematic review and individual patient-level meta-analysis of 7 randomized controlled trials comparing thrombectomy versus medical therapy in anterior circulation ischemic stroke published between January 1, 2010, and May 31, 2017 (Highly Effective Reperfusion Using Multiple Endovascular Devices collaboration), we analyzed the association between thrombectomy and reperfusion with maximal midline shift (MLS) on follow-up imaging as a measure of the space-occupying effect of cerebral edema in patients with large hemispheric infarction on pretreatment imaging, defined as diffusion-magnetic resonance imaging or computed tomography (CT)-perfusion ischemic core 80 to 300 mL or noncontrast CT-Alberta Stroke Program Early CT Score ≤5. Risk of bias was assessed using the Cochrane tool. RESULTS: Among 1764 patients, 177 presented with large hemispheric infarction. Thrombectomy and reperfusion were associated with functional improvement (thrombectomy common odds ratio =2.30 [95% CI, 1.32–4.00]; reperfusion common odds ratio =4.73 [95% CI, 1.66–13.52]) but not MLS (thrombectomy β=−0.27 [95% CI, −1.52 to 0.98]; reperfusion β=−0.78 [95% CI, −3.07 to 1.50]) when adjusting for age, National Institutes of Health Stroke Score, glucose, and time-to-follow-up imaging. In an exploratory analysis of patients presenting with core volume >130 mL or CT-Alberta Stroke Program Early CT Score ≤3 (n=76), thrombectomy was associated with greater MLS after adjusting for age and National Institutes of Health Stroke Score (β=2.76 [95% CI, 0.33–5.20]) but not functional improvement (odds ratio, 1.71 [95% CI, 0.24–12.08]). CONCLUSIONS: In patients presenting with large hemispheric infarction, thrombectomy and reperfusion were not associated with MLS, except in the subgroup with very large core volume (>130 mL) in whom thrombectomy was associated with increased MLS due to space-occupying ischemic edema. Mitigating cerebral edema-mediated secondary injury in patients with very large infarcts may further improve outcomes after reperfusion therapies.
引用
- Ng FC, Yassi N, Sharma G, et al. Cerebral Edema in Patients With Large Hemispheric Infarct Undergoing Reperfusion Treatment: A HERMES Meta-Analysis. Stroke. 2021. PMID: 34384229. doi:10.1161/STROKEAHA.120.033246
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。